พบ "Medical Devices"ทั้งหมด 197 ผลลัพธ์
A review of economic evaluation studies in Thailand: Are the data good enough to be used in decision making?
นักวิจัย: ภญ.ศิตาพร ยังคง The International Regulation of New Medical Technology: Health Technology Adoption in the European Union, North America, East Asia and in the Developing World
A Geneticist’s Research Turns Personal
http://www.nytimes.com/2012/06/03/business/geneticists-research-finds-his-own-diabetes.html?partner=rss&emc=rssHUMAN genome sequencing is already helping researchers find new treatments for illness. Now an unusual case study suggests that the benefits of sequencing may be enhanced in combination
A First: Organs Tailor-Made With Body’s Own Cells
STOCKHOLM — Andemariam Beyene sat by the hospital window, the low Arctic sun on his face, and talked about the time he thought he would die.Two and a half years ago doctors in Iceland, where Mr. Beyene was studying to be an engineer, discovered a golf-ball-size tumor growing into his windpipe. Despi
A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand (2014)
Abstract
Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I
A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand (2014)
Abstract
Objectives
In Thailand, axillary lymph node dissection (ALND) is the dominant form of treatment for breast cancer, even though the treatment often leaves patients with some degree of arm morbidity. Sentinel lymph node biopsy (SNB) is widely accepted globally as a preferable alternative pr
A cost – utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. (2013)
A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand.
Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1
1Health Intervention and Technology Assessment Program (HITAP),
18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions
The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co
10 / หน้า